Alteration of intrauterine growth trajectory is linked to metabolic diseases in adulthood. In mammalian and, specifically, human species, pregnancies through assisted reproductive technology (ART) are associated with changes in intrauterine growth trajectory. However, it is still unclear how ART alters intrauterine growth trajectory, especially reduced fetal growth in early to midgestation. In this study, using a mouse model, it was found that ART procedures reduce fetal and placental growth at Embryonic Day 10.5. Furthermore, ART leads to decreased methylation levels at H19, KvDMR1, and Snrpn imprinting control regions in the placentae, instead of fetuses.
INTRODUCTION
Epidemiological studies indicate a strong association between stress in utero and metabolic diseases later in life [1, 2] . These findings have led to the ''developmental origins of health and disease'' hypothesis, which states that stressful environmental conditions during sensitive periods of early life predispose to a series of metabolic diseases in adulthood [3] . Increasing evidence suggests that intrauterine growth trajectory is more appropriate for assessing fetal stress in utero, and altered intrauterine growth trajectory is linked to metabolic diseases in later life [4] [5] [6] . The intrauterine growth trajectory is determined by the placenta, which plays a critical role in controlling maternal-fetal resource allocation [7, 8] . Therefore, aberrant placental development and function is integrally linked to changes in intrauterine growth trajectory [9] .
Since the birth of the first test tube baby in 1978, more than 500 million infants have been born with the aid of assisted reproductive technologies (ARTs) [10] . Although a majority of infants are healthy, many studies have shown that children conceived through ART show increased incidence of vascular dysfunction and changes in glucose metabolism [11] [12] [13] . Furthermore, mouse models also indicate that ART, as a form of preimplantation stress, results in long-term health problems [14, 15] . Studies in human and animal models suggest that pregnancy through ART is linked to alterations in intrauterine growth trajectory that reduce fetal growth in early to midgestation, followed by accelerated fetal growth toward the end of gestation [4, 16] . However, it is still unclear how ART alters intrauterine growth, especially reduced fetal growth in early to midgestation.
Genomic imprinting is an epigenetic phenomenon in which certain genes (imprinted genes) are expressed in a parent-oforigin-specific manner [17] . ART procedures cause loss of imprinting (LOI) in the mouse and human preimplantation embryos [18] [19] [20] [21] . LOI in preimplantation embryo persists in mouse placentae instead of fetuses at midgestation [22] [23] [24] [25] [26] . Imprinted genes play a crucial role in placental development and regulation of nutrient transport capacity [27, 28] . ART affects placental nutrient transport and results in lower fetal weight at Embryonic Day (E) 18.5 in mice [29] . Our previous study also shows that the ART placentae exhibited histomorphological alterations with defects in placental layer segregation and abnormal migration of glycogen cells at E18.5 in mice, and perturbed genomic imprinting may contribute to these problems [30] . ART also resulted in an increased incidence of anomalous placentation, including abnormal shape, abnormal umbilical cord insertion, and vasa previa [31] [32] [33] . Therefore, it was hypothesized that perturbation of imprinting in placenta after ART may alter the expression of imprinted, as well as developmentally relevant genes resulting in abnormal placental development, which, in turn, affect the in utero fetal growth.
In this study, we investigated whether manipulation of embryo affects genomic imprinting and developmentally relevant genes in mouse concepti at E10.5. Mouse blastocysts were generated under three different experimental conditions: 1) in vivo group (the control group)-eggs were fertilized and developed in vivo to the blastocyst stage and then recovered by flushing the uterine horns with modified human tubal fluid medium; 2) in vivo culture (IVC) group-eggs were fertilized in vivo, collected at the one-cell stage, and cultured in vitro in potassium simplex optimized medium with amino acids (KSOMþAA) to the blastocyst stage; 3) the in vitro fertilization (IVF) group-eggs were fertilized in vitro and then in vitro cultured in KSOMþAA to the blastocyst stage. Sixteen blastocysts were subsequently transferred to the uteri of each pseudopregnant female mouse. The placentae and fetuses were collected at E10.5 for analysis.
Although ART resulted in reduced fetal growth at E10.5, the mean methylation levels of H19, KvDMR1, and Snrpn were not changed in fetal tissue. However, the placenta generated through ART exhibited reduced mean methylation levels and perturbed genomic imprinting. The expression of developmentally relevant genes and functional genes for nutrition transport was also affected in ART placentae. Overall, the results from this study suggest that ART disrupts epigenetic reprogramming events and perturbs developmental gene expression in the mouse placenta, which may affect placental development and function.
MATERIALS AND METHODS

Animals
Virgin 6-to 8-wk-old CD1 female mice, adult CD1 males, and Kunming vasectomized males were used. All animals were nested and caged at 218C-238C with a 12L:12D cycle, and had free access to standard chow and tap water. The present study was approved by the Committee on Ethics of Animals and Medicine of the Tangdu Hospital of the Fourth Military Medical University (permit number TDLL-2013051), and was carried out in accordance with the guidelines of the Committee on the Use of Live Animals in Teaching and Research of the Tangdu Hospital of The Fourth Military Medical University.
Experimental Design
All female mice were superovulated and assigned to the IVF, IVC, or control groups. In the control group, blastocysts were collected after in vivo fertilization and in vivo development. In the IVF group, blastocysts were obtained after IVF and development. In the IVC group, single-cell embryos were harvested from the oviducts after in vivo fertilization and blastocysts were obtained after in vitro culture and development. All embryos were then transferred to pseudopregnant females.
Superovulation
In the IVC and IVF groups, females were superovulated by intraperitoneal injection of 7.5 IU (0.15 ml) pregnant mare serum gonadotropin (ProSpec, Ness-Ziona, Israel), followed by an intraperitoneal injection of 5 IU (0.1 ml) of human chorionic gonadotropin (ProSpec, Ness-Ziona, Israel) 48 h later.
In Vitro Fertilization
Conventional IVF was performed using human tubal fluid (HTF; Millipore, Billerica, MA) medium. The collected sperm from the cauda epididymis of adult male CD1 mice were suspended in the HTF medium (Millipore) for at least 30 sec and then placed in a dish in an incubator for capacitation. Capacitation of the spermatozoa was achieved by maintaining a temperature of 378C under 5% CO 2 and 95% humidity for 1-2 h. The preincubated and capacitated sperm suspension was gently added to the freshly ovulated cumulus-oocyte complexes to obtain a final motile sperm concentration of 1-2310 6 /ml, determined using a hemocytometer. Sperm and oocytes were cocultured for 8 h in insemination medium.
Embryo Culture
In vivo or in vitro fertilized eggs (22-23 h after hCG), as determined by the presence of two pronuclei, were then cultured under optimized culture conditions (KSOMþAA; Millipore) and assessed for their developmental efficiency in vitro.
Embryo Transfer Recipients
Kunming females of at least 6 wk of age were mated with vasectomized Kunming males 4 days prior to embryo transfer. The morning after mating, females were checked for the presence of a vaginal plug, which indicated Day 0.5 of pseudopregnancy. Embryos were then transferred to the uteri of the pseudopregnant females on Pseudopregnancy Day 3.5 according to standard procedures.
Isolation of Fetal and Placental Tissues
The fetal and placental tissues of the control, IVC, and IVF groups were collected by a researcher who was blinded to the study group at E10.5. The placentae, yolk sacs, and fetuses were mechanically separated, and the developmental stage was determined. The crown-rump length was measured using light microscopy with an eyepiece graticule. The whole fetus and placenta were snap frozen in separate tubes using liquid nitrogen and stored at À808C until further use.
Methylation Studies
Genomic DNA was extracted from the placentae using the Blood and Tissue DNA Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The concentration and purity of the DNA were determined using absorbance at 260 and 280 nm. DNA (1 lg) was treated with bisulfite using the EpiTect Bisulfite Kit (Qiagen) following the manufacturer's protocol.
PCR primers were designed using the EpiDesigner software (Sequenom, San Diego, CA). The oligo sequences of forward and reverse primers are listed in Supplemental Table S1 (Supplemental Data are available online at www. biolreprod.org). The amplified fragments were analyzed on a MassARRAY platform (Sequenom) at the Beijing Genomics Institute at Shenzhen. Locusspecific PCR amplification was performed using the T7 promoters to generate in vitro transcription of the amplified fragments. These transcripts were then subjected to enzymatic RNA base pair cleavage. The resulting fragments differ in size and mass depending on the sequence changes generated through bisulfite treatment. The fragment mass was determined using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
The quantitative methylation data for each CpG site, or aggregates of multiple CpG sites, obtained were analyzed using the EpiTYPER software (Sequenom). The mean methylation levels were obtained using the weighted mean.
Extraction of RNA, Preparation of cDNA, and Real-Time PCR A pool of 12 placental samples from the same group was used for the extraction of total RNA. RNA was extracted with TRIzol (Life Technologies, Carlsbad, CA), according to the manufacturer's instructions, and treated with DNase I to eliminate genomic DNA contamination. RT was accomplished using a commercially available first-strand cDNA synthesis kit (Qiagen). The RT reactions were performed following the manufacturer's protocol to reverse transcribe 1 lg of total RNA. Real-time PCR was performed using the CFX96 real-time PCR instrument (Bio-Rad, Hercules, CA) and SYBR Green JumpStart Taq ReadyMix for Q-PCR, according to the manufacturer's protocol (Sigma-Aldrich, St. Louis, MO). Gene expression was normalized using the housekeeping gene, Gapdh, as the reference gene. The primer sequences for the genes analyzed are listed in Supplemental Tables S2-S6 . Primer sequences were obtained from Primer Bank or designed using Primer Express. Samples were analyzed using the DDCt method. The full names of genes in this study are listed in Supplemental Table S7. LI ET AL.
Statistical Analysis
Quantitative data are expressed as means 6 SD. Data were subjected to analysis of variance test for assessing any significant difference among the three groups. The least significant difference post hoc test was used to examine any significant difference between groups. P , 0.05 was considered significant. The litter served as the unit of comparison.
RESULTS
ART Restricted Fetal Growth in Mice
After transfer of a similar number of blastocysts to the recipients, it was found that the rate of embryonic implantation did not differ between the IVC, IVF, and control groups ( Fig.  1A ; Table 1 ). However, the rate of abortion in the IVF group was significantly higher than in the IVC and control groups (P , 0.01; Fig. 1B ; Table 1 ). These results suggested that IVF affected the survival of embryos and increased the rate of fetal loss after implantation. Fetal growth was also evaluated at E10.5. It was found that the fetal crown-rump length in both the IVC (n ¼ 56, six litters) and IVF (n ¼ 54, seven litters) groups was significantly reduced compared with the control group (n ¼ 61, six litters) ( Table 2 ). No differences in the fetal crown-rump length between the IVC and IVF groups were found. The placental weight of the IVC (n ¼ 56, six litters) and IVF (n ¼ 54, seven litters) groups was significantly lower than in the control group (n ¼ 61, six litters; Fig. 1D ; 41.1 6 6.1 mg vs. 43.4 6 6.4 mg, P , 0.05; 39.6 6 7.9 mg vs. 43.4 6 6.4 mg, P , 0.01; Table 2 ). However, there were no differences in placental weight between the IVC and IVF groups. The results suggest that ART restricts fetal growth and reduces placental growth in mice.
Unaltered Methylation Levels of Multiple Imprinting Control Regions in ART-Derived Fetuses
To determine possible aberrations in the normal fetuses isolated at E10.5, the DNA methylation level was analyzed using MassARRAY assays for one paternally methylated imprinting control region (ICR) (H19) and two maternally methylated ICRs (Snrpn and KvDMR1). The MassARRAY application for quantitative DNA methylation analysis combines base-specific enzymatic cleavage with matrix-assisted Fig. 2A ). In the 32 CpG sites at KvDMR1, fetuses from the control, IVC, and IVF groups presented a mean methylation level of 0.395 6 0.014, 0.399 6 0.013, and 0.390 6 0.016, respectively (Fig. 2B) , and no significant difference was observed in fetuses of these three groups (P . 0.05). Similarly, the methylation levels of 11 CpG sites at the Snrpn ICR were also examined. Fetuses from the IVC and IVF groups showed a mean methylation level of 0.418 6 0.033 and 0.417 6 0.051, respectively, compared with 0.415 6 0.054 from the control group (Fig. 2C ). No significant difference was observed between the IVC, IVF, and control groups (P . 0.05). The methylation levels of individual CpG sites within H19 ICR (Fig. 2D) , KvDMR1 (Fig. 2E) , and Snrpn ICR (Fig. 2F) were also evaluated. The methylation levels of a few CpG sites varied between ART and control groups. A) The mean methylation levels of the H19 ICR were analyzed in the E10.5 fetuses from the in vivo, IVC, and IVF groups. B) The mean methylation levels of KvDMR1 were analyzed in the E10.5 fetuses from the in vivo, IVC, and IVF groups. C) The mean methylation levels of the Snrpn ICR were analyzed in the E10.5 fetuses from in vivo, IVC, and IVF groups. D) Methylation levels of individual CpG sites in H19 ICR were compared between samples from in vivo, IVC, and IVF groups. E) Methylation levels of individual CpG sites in KvDMR1 were compared between samples from in vivo, IVC, and IVF groups. F) Methylation levels of individual CpG sites in Snrpn ICR were compared between samples from in vivo, IVC, and IVF groups. *Differ significantly versus in vivo group (P , 0.05). Error bars represent SD. n.s., not significant.
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Decreased Methylation Levels of Multiple ICRs in ARTDerived Placentae
The methylation level of each CpG site within the target sequences of H19 ICR, KvDMR1, and Snrpn ICR in placentae was also obtained using the MassARRAY assays. The mean methylation level of all CpG sites at each target sequence was analyzed first. With regard to the 13 CpG sites at H19 ICR, placentae from the IVC and IVF groups showed a mean methylation level of 0.401 6 0.037 and 0.388 6 0.042, respectively, compared with 0.462 6 0.040 in the control group (Fig. 3A) . The H19 ICR mean methylation level was significantly decreased in the IVC and IVF groups compared with the control group (P , 0.01 and P , 0.01, respectively). However, no significant difference was observed between the IVC and IVF groups (P . 0.05). In the 32 CpG sites at KvDMR1, placentae from the IVC and IVF groups presented a mean methylation level of 0.412 6 0.036 and 0.405 6 0.049 compared with 0.461 6 0.065 from the control group (Fig.  3B ). The KvDMR1 mean methylation level was significantly decreased in the IVC and IVF groups compared with the control group (P , 0.05 and P , 0.01, respectively), but no significant difference was observed between the IVC and IVF groups (P . 0.05). Similarly, the methylation levels at 11 CpG sites at the Snrpn ICR were also examined. Placentae from the IVC and IVF groups showed a mean methylation level of 0.356 6 0.059 and 0.325 6 0.032, respectively, compared with 0.391 6 0.026 from the control group (Fig. 3C) . The Snrpn ICR mean methylation level was significantly decreased in the IVC and IVF groups compared with the control group (P , 0.05 and P , 0.01, respectively), but no significant difference was observed between the IVC and IVF groups (P . 0.05). The methylation levels of individual CpG sites within H19 ICR (Fig. 3D) , KvDMR1 (Fig. 3E) , and Snrpn ICR (Fig. 3F) were also evaluated. We also found that the methylation levels of a few CpG sites were different between ART and control groups.
Expression of Multiple Imprinted Genes Are Perturbed in ART-Derived Placentae
The expression of imprinted genes in the control, IVC, and IVF groups was also compared in the placentae at E10.5. The paternally expressed imprinted gene Snrpn was significantly upregulated, whereas Dlk1, Igf2, Kcnq1ot1, Ndn, Peg3, Plagl1, A) The mean methylation levels of the H19 ICR were analyzed in the E10.5 placentae from the in vivo, IVC, and IVF groups. B) The mean methylation levels of KvDMR1 were analyzed in the E10.5 placentae from the in vivo, IVC, and IVF groups. C) The mean methylation levels of the Snrpn ICR were analyzed in the E10.5 placentae from in vivo, IVC, and IVF groups. D) Methylation levels of individual CpG sites in H19 ICR were compared between samples from in vivo, IVC, and IVF groups. E) Methylation levels of individual CpG sites in KvDMR1 were compared between samples from in vivo, IVC, and IVF groups. F) Methylation levels of individual CpG sites in Snrpn ICR were compared between samples from in vivo, IVC, and IVF groups. *Differ significantly versus in vivo group (P , 0.05). Error bars represent SD. n.s., not significant.
ASSISTED REPRODUCTION DISRUPTS PLACENTAL FUNCTION
Sgce, Peg10, Peg11, Zdbf2, and Sfmbt2 were downregulated in both the IVC and IVF groups compared with the control group (Fig. 4A) . A total of 3 (Gtl2, Igf2r, and Grb10) of the 12 maternally expressed imprinted genes were found to be significantly downregulated in the IVC and IVF groups when compared with the control group (Fig. 4B) . The expression of Cd81, Cdkn1c, Dcn, Gnas, H19, Mash2, Gatm, and Phlda2 was upregulated in the IVC and IVF groups (Fig. 4B) . Osbp15 was upregulated only in the IVF group (Fig. 4B) .
The paternally inherited X-chromosome was inactivated in the placental tissue of mice, and studies have identified five Xlinked genes (Exs1, Chm, Cited1, Nrk, and Plac1) with crucial roles in placental function. In this study, four X-linked genes (Exs1, Chm, Cited1, and Nrk) were significantly downregulated in the IVC and IVF groups when compared with the control group (Fig. 5) . However, Plac1 was upregulated, but only in the IVF group (Fig. 5) .
ART Disrupts Expression of Placental Developmental and Functional Genes
The expression of several key genes underlying placental development in the IVC and IVF groups was analyzed and compared with that of the control group using quantitative RT-PCR (Fig. 6) . The transcription factor, glial cell missing 1 (Gcm1), Syna, and Synb are essential for the development of syncytiotrophoblasts in the labyrinthine zone, and the expression of Gcm1 and Syna was significantly downregulated in the IVC and IVF groups, but the expression of Synb was not affected. The kinase insert domain protein receptor (Flk1/Kdr), which is an indicator of fetal vasculature and plays a key role in vascular development, was significantly downregulated in the placentae of the IVC and IVF groups. The prolactin family 8 subfamily A member 8 (Prl8a8) gene, trophoblast-specific protein alpha (Tpbpa), and trophoblast-specific protein beta (Tpbpb), which are specifically expressed in spongiotrophoblast cells, were markedly downregulated in both the IVC and IVF groups. Protocadherin 12 (Pcdh12) is expressed exclusively in glycogen cells of the junctional zone, and the expression of Pcdh12 was significantly downregulated. The expression of heart and neural crest derivatives expressed transcript 1 (Hand1), which is essential for giant trophoblast cell differentiation, was markedly downregulated in both the IVC and IVF groups. These results may reflect abnormalities in the placentae of the IVC and IVF groups. Therefore, ART disrupts the expression of placental developmental genes in the mouse.
The expression of several key genes for placental function in the IVC and IVF groups was also analyzed and compared with that of the control group using quantitative RT-PCR. The expression of genes for several enzymes critical for glycogen metabolism, including glycogen synthases 1 and 2 (Gys1 and Gys2) and 1,4-glucan branching enzyme (Gbe1), was also compared with that of the control group. Gys2 and Gbe1 were markedly downregulated in the placentae of the IVC and IVF groups, but Gys1 was not affected. Hypoxia-induced growth factor 1-alpha (Hif1a), which was crucial for placental vascularization, was downregulated in the IVC and IVF groups. The enzyme, 11b-hydroxysteroid dehydrogenase type 2 (Hsd11b2), which catalyzed the intracellular inactivation of glucocorticoids, is highly expressed within the placenta and plays an important part in fetal development and programming. In this study, the expression of Hsd11b2 was markedly downregulated in the IVC and IVF groups. Studies show that Mapk14 is an important regulator of placental Hsd11b2 [36] . In this study, it was found that Mapk14 was significantly downregulated in the placentae of the IVC and IVF groups. Signal transducer and activator of transcription 4 (Stat4) is thought to be essential for regulating the differentiation of T helper cells and maintaining adaptive immune responses. The expression of Stat4 was downregulated in the IVC and IVF groups.
ART Downregulates Placental Nutrient Transporters
The expression and activity of a range of nutrient transporters are related to the capacity of the placenta to transport these nutrients to the fetus [37] . As the expression of developmentally and functionally relevant genes in the ART placenta was abnormal, we investigated whether IVF affected the expression of nutrient transporter genes.
It was found that the expression of a majority of nutrient transporter genes was significantly downregulated in the placentae of both the IVC and IVF groups at E10.5 (Fig. 7) . The system A amino acid transporters are crucial for the transport of neutral amino acids, and reduced system A activity has been shown to precede impaired fetal growth [38] . In this study, the expression of Slc38a1 and Slc38a4 was significantly downregulated in the placentae of the IVC and IVF groups. Placental transport of glucose is mediated through specific 
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glucose transporters, of which Slc2a1 and Slc2a3 are believed to encode the primary glucose transporters in the placenta. The levels of expression of Slc2a1 and Slc2a3 in the placentae of the three groups were detected. However, Slc2a1 and Slc2a3 were significantly increased in the placentae of the IVC and IVF groups. The expression of Ca þþ transporting ATPase (Atp2a3), which is a calcium pump in the placenta, showed a significant decrease in the IVC and IVF placentae. Na þ /K þ -ATPase (Atp1a1), which mediates Na þ and K þ transport, was markedly downregulated in the placentae of the ART groups. Slc1a3 encodes a member of a high-affinity glutamate transporter family, and Slc1a3 showed a decrease in the mRNA expression in the ART versus control group. It was also found that sodium-and chloride-dependent taurine transporter (Slc6a6), thiamine transporter 1 (Slc19a2), and anion transporter (Slc26a7) were significantly downregulated in the placentae of the IVC and IVF groups. Some organic cation transporters, such as solute carrier family 22, member 3 (Slc22a3) and solute carrier family 22, member 18 (Slc22a18), were also downregulated in the placentae of the IVC and IVF groups.
DISCUSSION
In this study, the effects of ART on placental and fetal development, placental genomic imprinting, and the development and function of relevant genes were extensively characterized. The fetal crown-rump length and the placental weight were significantly decreased in the IVC and IVF groups compared with the control group. The impact of ART on methylation of imprinted genes in the mouse fetuses and placentae was also analyzed. The fetal tissues from naturally conceived and ART-derived embryos exhibited normal methylation levels of all three ICRs of H19, KvDMR1, and Snrpn. However, the placentae from the IVC and IVF conceptus showed reduced methylation levels at multiple ICRs compared with those of the controls. The expression of imprinted genes was significantly disrupted in the ART-derived placentae. The expression of key developmental genes of the placenta was disrupted by ART, and ART leads to the downregulation of a majority of nutrient transporter genes. Based on these findings, we hypothesize that ART could affect the placental development and function, which would affect the fetal growth and reprogramming, and thus influence the long-term health of offspring.
We found that ART was associated with placental overgrowth and reduced fetal weight at late gestation in mouse in our previous study [30] . In this study, it was found that the fetal crown-rump length was significantly decreased in the IVC and IVF groups compared with the control group at E10.5, suggesting that ART-induced intrauterine growth restriction can be retraced to Day 10.5 of pregnancy in mice. ART procedures were associated with reduced placental weight and growth at E10.5, followed by overgrowth in the placental size toward the end of gestation.
The placental epigenome is crucial for placental development and function, and this is well demonstrated by the link between placental imprinting status and fetal growth [39] . Studies have shown that imprinted genes were susceptible to embryo manipulation. In this study, the methylation levels of H19 ICR, KvDMR1, and Snrpn ICR remained unchanged in fetal tissues, but were significantly reduced in IVC and IVF placentae. This finding is consistent with previous reports that revealed selective LOI in the placenta following embryo manipulation [24, 25, 40] . The data presented here suggest that the genomic imprinting of the placenta was susceptible to ART manipulation. The results suggest that the methylation levels of H19 ICR and KvDMR1 were significantly reduced in E10.5 IVF placentae. At E14.5, the methylation levels of H19 ICR and KvDMR1 in the placentae of the IVF group were not significantly different from those of the control group, while, at E18.5, the methylation levels of H19 ICR and KvDMR1 in the IVF placentae were considerably higher than in the control group [30] . These results indicate that methylation levels of H19 ICR and KvDMR1 in the ART placentae were gradually increased relative to the placentae of the control group from E10.5 to E18.5 in mice. The methylation levels of H19 ICR and KvDMR1 in the IVF placentae changed from lower than in the control group at E10.5 to higher levels at E18.5. During this process, compensatory placental overgrowth also occurred in mice.
It was also found that the expression of imprinted genes in the placentae of normally developed E10.5 conceptus was disrupted by IVC and IVF. A total of 11 of 13 paternally expressed imprinted genes were downregulated in the placentae of the IVF group, and most of them played an important role in placental development and function. As a modulator of fetal growth and development, Igf2 regulates the expression of placental nutrient transport systems [27] . Targeted deletion of LI ET AL. the long, noncoding RNA Kcnq1ot1 results in placental growth restriction [41] . Peg10 is required for the differentiation of placental spongiotrophoblast and labyrinth [41] . Peg11/Rtl1 is essential for the development of placental labyrinth and nutrient passive transport [42] . Sfmbt2 plays a key role in the maintenance of trophoblast cell types [43] . All the maternally expressed genes in the placenta analyzed were disrupted by IVC and IVF. A total of 9 of the 12 maternally expressed genes tested were upregulated. H19 and Cdkn1c negatively regulate cell proliferation. A higher expression of H19 and Cdkn1c in the placentae of the IVC and IVF groups may be associated with reduced placental growth [41] . The maternally expressed gene, Phlda2, negatively regulates the placental growth and limits the glycogen storage in the placentae of mice [44] . Phlda2 was upregulated in the placentae of the IVC and IVF groups. In summary, it was found that, in the IVC and IVF placentae, a vast majority of parentally expressed imprinted genes (Dlk1, Igf2, Kcnq1ot1, Ndn, Peg3, Plagl1, Sgce, Peg10, Peg11, Zdbf2, Sfmbt2) were downregulated, whereas a vast majority of maternally expressed imprinted genes (CD81, Cdkn1c, Dcn, Gnas, H19, Mash2, Gatm, Phlda2) were upregulated. Many studies support the kinship theory (the parental conflict hypothesis), which states that the paternally expressed imprinted genes enhance fetal growth, whereas the maternally expressed genes repress fetal growth in uterus [17] . Downregulation of the parentally expressed genes and upregulation of the maternally expressed genes in the placentae of the IVC and IVF groups result in reduced growth of the placentae and fetuses. We also found that some X-linked genes, which are critical for placental development and function, were severely disrupted by ART.
The expression of key genes that regulate the placental development and function was affected by IVC and IVF. Hand1, which is essential for giant trophoblast cell differentiation, was downregulated in the IVC and IVF groups. Tpbpa, Tpbpb, Prl8a8, and Pcdh12 mediate the development of the spongiotrophoblast layer, and all of them were downregulated in the placentae of the IVC and IVF groups. Gcm1, Syna, and Flk1 play key roles in the development of labyrinthine, and were all downregulated in the placentae of the ART groups. Hif1a, which is crucial for placental vascularization, was downregulated in the IVC and IVF groups. The decreased level of Hsd11b2 is associated with low birth weight and weight gain [45] . It was found that the level of Hsd11b2 expression was decreased in the IVC and IVF groups. Stat4, which is essential for maintaining adaptive immune responses during pregnancy, was downregulated in the IVC and IVF placentae. Genomic imprinting is the most widely studied epigenetic phenomenon in the placenta. It is an important indicator of global epigenetic stability, with studies focused on the effects of ART on methylation and expression of imprinted genes [46] . However, altered methylation and expression of nonimprinted genes by ART may be equally frequent and important [47] . The expression of a few nonimprinted genes that regulate the development and function of the placenta is regulated by DNA methylation, and the methylation of these genes is susceptible to environment [48, 49] . In this study, we found that the expression of genes that regulate placental development and function was affected by ART. To elucidate the effect of ART on placental development and function, the impact of ART on the methylation of nonimprinted genes regulating placental function should be studied further.
The expression and activity of nutrient transporters are related to placental transport of these nutrients to the fetus [37] . In this study, a vast majority of nutrient transport genes was downregulated in the placentae of the IVC and IVF groups.
The downregulated expression of nutrient transporter genes in the ART-placenta, including amino acid transporters, Lpl, ion channels, taurine transporter, thiamine transporter, and organic cation transporters, may induce fetal growth retardation in the IVC and IVF groups. However, it was found that the glucose transporters (Slc2a1 and Slc2a3) were upregulated in the IVC and IVF groups.
Studies have reported an increased risk of metabolic disorders in IVF children and mice [13, 14] . As embryo manipulation leads to LOI in preimplantation embryo, there is a widespread concern that LOI persists during later stages of development, and leads to long-term effects of epigenetic errors in later life [18] . LOI persisted in the extraembryonic tissues (placenta and yolk sac), but not in the fetal tissues at the midgestation stage of the mouse [22, 23, 25, 26] . These results indicate that fetal, but not placental, tissues restored genomic imprinting. Higher placental weight, increased placental steroid glucuronidation, altered placental metabolism, and impaired nutrient transport were associated with epigenetic errors in midgestation placenta, and documented at later gestation in mice [29, 50, 51] . Our previous report found that the ART resulted in abnormities with placental layer segregation and glycogen cell migration at E18.5 [30] . In this study, we found that ART disrupted genomic imprinting and developmentally and functionally relevant genes in the placenta at E10.5. We hypothesized that placental dysfunction is a critical factor that leads to higher rates of negative outcomes in ART pregnancies and predisposition to adultonset disease (Fig. 8) . Based on these studies, we suggest that disruption of epigenetic patterns in the placenta by ART leads to aberrant gene expression and placental development and function. In turn, placental dysfunction, including perturbed placental endocrinology, altered placental metabolism, and impaired nutrient transport result in fetal maladaptation and changes in the fetal intrauterine growth trajectory. Disruptions to normal fetal development may result in epigenetic errors in organs and that lead to predisposition to adult metabolic disease.
It is very important to elucidate how aberrations in imprinting are induced by embryo manipulation. Disruption of epigenetic programming may be an adaptive response of the embryos to suboptimal preimplantation environment [52] . Selective LOI in the placenta following ART may be attributed to different DNA methylation dynamics between the somatic tissue and extraembryonic tissues. After fertilization, the zygote undergoes global demethylation, until the blastocyst stage [53] . At the blastocyst stage, the methylation level is the lowest. After hatching, de novo methylation was observed specifically in the inner cell mass (ICM), but not in the trophectoderm (TE). The TE-derived cells (placenta) remain relatively hypomethylated compared with the somatic cells, due to differential expression of DNA methyltransferase 3b (DNMT3B) in the two cell layers (TE and ICM) of blastocyststage embryo [54] . DNMT3B protein is more highly expressed in embryonic lineage than in extraembryonic lineage [55] . ART-induced LOI may be attributed to changes in DNMT expression in the preimplantation stage. Studies have shown that in vitro culture conditions (serum level and high glucose concentration), aging, vitrification, and cryopreservation alter the expression of DNMTs in preimplantation stage [56] . However, it is unknown yet how the expression and activity of DNMTs are regulated in oocytes and preimplantation embryos. Identification of the underlying mechanisms may provide us new ways to improve ARTs and prevent epigenetic disorders in children conceived via ART.
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